From the Qtr update AHR indicated they would receive the INDEPENDENT Scoping study within TWO weeks that?s the end of next week. (Feb 11). Lets hope they are not let down again.
Also per the announcement they anticipate at least DOUBLING the Antimony resource.
As mentioned this (Scoping Study) should form a KEY part of the reply to the bidder statement and MOSTIMPORTANTLY the INDEPENDENT negotiation tool for the bid and any other party interested.
I have the greatest respect for the Directors and I do not see them short selling themselves and other shareholders.
AHR will continue to trade during the majority of the process. Therefore bidder or potential bidder can continue to acquire stock under the current bid price.
If there is a new successful bidder the current bidder will make a nice profit.
AHR Price at posting:
26.0¢ Sentiment: Hold Disclosure: Held
